Modification of the teratogenicity and mutagenicity of cyclophosphamide with thiol compounds.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D003520:Cyclophosphamide / Q000378:metabolism / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005978:Glutathione / Q000494:pharmacology; D008298:Maleates / Q000494:pharmacology; D009153:Mutagens / Q000633:toxicity*; D011247:Pregnancy; D051381:Rats; D013438:Sulfhydryl Compounds / Q000494:pharmacology*
D008298:Maleates; D009153:Mutagens; D013438:Sulfhydryl Compounds; D003520:Cyclophosphamide; C014476:diethyl maleate; D005978:Glutathione